Structure-distribution relationship studies of 99mTc-2,3-diamine complexes

Q. Salako1, A.E. Theobald2
1Department of Pharmaceutical Chemistry, College of Medicine, University of Lagos, Lagos, Nigeria
2King's College (KQC), Department of Pharmacy, Chelsea Campus, London SW3 6LX, U.K.

Tài liệu tham khảo

Chiotellis, 1980, Tc-99m labelled N-substituted carbamoyl iminodiacetates: Relationship between structure and biodistribution, Int. J. Nucl. Med. Biol., 7, 1, 10.1016/0047-0740(80)90002-9 Hansch, C.; Leo, A. Substituent Constants for Correlation Analysis in Chemistry and Biology. New York: Wiley. Loberg, 1976, Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid, J. Nucl. Med., 17, 633 Marzilli, 1980, Tc-99m radiopharmaceuticals—Uses, problems, potential applications in nuclear medicine, 91 Munze, 1982, Tc-99m radiopharmaceuticals, structure-activity relationships, J. Labelled Compd. Radiopharm., 19, 1453 Nunn, 1983, A structure distribution approach leading to development of Tc-99m-mebrofenin: An improved cholescintigraphic agent, J. Nucl. Med., 24, 423 Salako, 1989, Tc-99m labelling of solubilized ligands (I), Appl. Radiat. Isot., 40, 621, 10.1016/0883-2889(89)90118-4 Taylor, 1978, Biochemical aspects of radiopharmaceutical design Washburn, 1982, Effect of structural alteration on the uptake and clearance of primary aliphatic amines in rat lung, J. Labelled Compd. Radiopharm., 19, 1282